Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Regel Therapeutics

Regel Therapeutics is an early-stage startup based in Cambridge, MA and San Francisco, CA that is pioneering precision gene therapies.

  • Kathryn Allaway Head of R&D